BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37501549)

  • 1. Children's Oncology Group's 2023 blueprint for research: Bone tumors.
    Reed DR; Grohar P; Rubin E; Binitie O; Krailo M; Davis J; DuBois SG; Janeway KA
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30583. PubMed ID: 37501549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children's Oncology Group's 2013 blueprint for research: bone tumors.
    Gorlick R; Janeway K; Lessnick S; Randall RL; Marina N;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1009-15. PubMed ID: 23255238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group.
    Shulman DS; Klega K; Imamovic-Tuco A; Clapp A; Nag A; Thorner AR; Van Allen E; Ha G; Lessnick SL; Gorlick R; Janeway KA; Leavey PJ; Mascarenhas L; London WB; Vo KT; Stegmaier K; Hall D; Krailo MD; Barkauskas DA; DuBois SG; Crompton BD
    Br J Cancer; 2018 Aug; 119(5):615-621. PubMed ID: 30131550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
    Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the Treatment of Pediatric Bone Sarcomas.
    Grohar PJ; Janeway KA; Mase LD; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2017; 37():725-735. PubMed ID: 28561686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children's Oncology Group (COG) New Agents for Ewing Sarcoma Task Force.
    Bailey K; Cost C; Davis I; Glade-Bender J; Grohar P; Houghton P; Isakoff M; Stewart E; Laack N; Yustein J; Reed D; Janeway K; Gorlick R; Lessnick S; DuBois S; Hingorani P
    F1000Res; 2019; 8():. PubMed ID: 31031965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.
    Fox E; Patel S; Wathen JK; Schuetze S; Chawla S; Harmon D; Reinke D; Chugh R; Benjamin RS; Helman LJ
    Oncologist; 2012; 17(3):321. PubMed ID: 22363068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma.
    DuBois SG; Krailo MD; Buxton A; Lessnick SL; Teot LA; Rakheja D; Crompton BD; Janeway KA; Gorlick RG; Glade-Bender J
    Arch Pathol Lab Med; 2021 Dec; 145(12):1564-1568. PubMed ID: 33769463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience.
    Daw NC; Mahmoud HH; Meyer WH; Jenkins JJ; Kaste SC; Poquette CA; Kun LE; Pratt CB; Rao BN
    Cancer; 2000 May; 88(9):2172-80. PubMed ID: 10813731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of location of inpatient cancer care on patients with Ewing sarcoma and osteosarcoma-A population-based study.
    Alvarez E; Malogolowkin M; Pollock BH; Li Q; Johnston E; Marina N; Wun T; Thorpe S; Keegan T
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28998. PubMed ID: 33720485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of pediatric bone tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
    Cederberg KB; Iyer RS; Chaturvedi A; McCarville MB; McDaniel JD; Sandberg JK; Shammas A; Sharp SE; Nadel HR
    Pediatr Blood Cancer; 2023 Jun; 70 Suppl 4(Suppl 4):e30000. PubMed ID: 36250990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
    Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
    Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.
    Schuetze SM
    J Natl Compr Canc Netw; 2007 Apr; 5(4):449-55. PubMed ID: 17442235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study.
    Geyer JR; Balis FM; Krailo MD; Heideman R; Broxson E; Sato JK; Poplack D; Bleyer WA
    Invest New Drugs; 1996; 13(4):337-42. PubMed ID: 8824353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
    Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
    Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group.
    Collier AB; Krailo MD; Dang HM; DuBois SG; Hawkins DS; Bernstein ML; Bomgaars LR; Reed DR; Gorlick RG; Janeway KA
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29333. PubMed ID: 34496122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of locus of care on outcomes in adolescents and young adults with osteosarcoma and Ewing sarcoma treated at pediatric versus adult cancer centers: An IMPACT cohort study.
    Mortazavi M; Baxter NN; Gupta S; Gupta AA; Lau C; Nagamuthu C; Nathan PC
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29458. PubMed ID: 35029312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children's Oncology Group's 2023 blueprint for research: Epidemiology.
    Lupo PJ; Marcotte EL; Scheurer ME; Poynter JN; Spector LG;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30566. PubMed ID: 37449937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
    Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
    Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapeutic concepts for bone sarcomas].
    Kager L; Bielack S
    Unfallchirurg; 2014 Jun; 117(6):517-22. PubMed ID: 24903502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.